Zymeworks (ZYME) analyst forecast and price target
Analyst forecast
Consensus of 12 analyst ratings
Based on 6 analyst targets
Recent analyst ratings
| Firm | Action | Rating | Price target | Date |
|---|---|---|---|---|
| HC Wainwright & Co. | Maintained | Buy | $55.00 from $51.00 | Aug 26, 2026 |
| Citigroup | Maintained | Buy | $38.00 from $37.00 | Aug 26, 2026 |
| Citizens | Maintained | Market Outperform | $32.00 | Aug 26, 2026 |
| B. Riley Securities | Maintained | Buy | $44.00 from $40.00 | Aug 10, 2026 |
| Truist Securities | Maintained | Buy | $32.00 from $31.00 | Aug 7, 2026 |
| Wells Fargo | Maintained | Overweight | $40.00 from $37.00 | Aug 7, 2026 |
| HC Wainwright & Co. | Maintained | Buy | $51.00 from $46.00 | Aug 5, 2026 |
| Truist Securities | Maintained | Buy | $31.00 from $28.00 | Jul 7, 2026 |
| Wells Fargo | Maintained | Overweight | $37.00 from $34.00 | Jun 30, 2026 |
| HC Wainwright & Co. | Maintained | Buy | $46.00 | Jun 3, 2026 |
| Wells Fargo | Maintained | Overweight | $34.00 from $33.00 | May 8, 2026 |
| Evercore ISI Group | Maintained | Outperform | $48.00 from $33.00 | Mar 9, 2026 |
| HC Wainwright & Co. | Maintained | Buy | $46.00 from $32.00 | Mar 6, 2026 |
| Leerink Partners | Maintained | Outperform | $58.00 from $52.00 | Mar 3, 2026 |
| Stifel | Maintained | Buy | $47.00 from $40.00 | Mar 3, 2026 |
| Truist Securities | Initiated Coverage | Buy | $40.00 | Dec 17, 2025 |
| Wells Fargo | Upgraded | Equal-Weight → Overweight | $33.00 from $25.00 | Dec 12, 2025 |
| Citizens | Initiated Coverage | Market Outperform | $32.00 | Dec 3, 2025 |
| B. Riley Securities | Maintained | Buy | $40.00 from $30.00 | Nov 21, 2025 |
| Stifel | Maintained | Buy | $40.00 from $30.00 | Nov 19, 2025 |
Frequently asked questions
What is the price target for ZYME stock?
The average 12-month analyst price target for Zymeworks (ZYME) is $40.17, with a high estimate of $55.00 and a low of $32.00, across 6 analysts.
Is ZYME a buy, sell, or hold?
Analysts covering Zymeworks currently average a Buy rating: 12 buy, 0 hold and 0 sell, from 12 analysts. Ratings reflect analyst opinion, not investment advice.
What upside do analysts see for ZYME?
The average price target of $40.17 implies 36.57% upside from the last price of $29.41.
What is the latest analyst rating on ZYME?
On Aug 26, 2026, HC Wainwright & Co. maintained Zymeworks at Buy with a price target of $55.00.
Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.